Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07660315 · ClinicalTrials.gov registry record · NA
Goji Berry and Vasomotor Symptoms Pilot Study
A NA study, sponsored by University of California, Davis.
- Not yet
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT07660315 is a NA study that has not yet begun recruiting, run by University of California, Davis. The registered enrollment target is 6 participants.
The verdict
NCT07660315, a NA study, has not yet begun recruiting, sponsored by University of California, Davis.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to compare two forms of goji berry powder-whole goji berry powder and goji juice powder-in peri- and postmenopausal women aged 40-65 years who experience frequent vasomotor symptoms (hot flashes). The study aims to determine which formulation is more promising for a future larger trial by evaluating effects on HDL cholesterol function, vasomotor symptoms, cognitive performance, and participant acceptability. The main questions it aims to answer are: Does whole goji berry powder produce a greater improvement in HDL cholesterol efflux capacity (CEC) over 30 days compared with goji juice powder? Are changes in HDL function associated with changes in hot flash burden, cognitive performance, and self-reported cognitive symptoms? Researchers will compare participants assigned to whole goji berry powder with participants assigned to goji juice powder to evaluate differences in HDL function, vasomotor symptoms, cognitive outcomes, and intervention acceptability. Participants will: Consume one mug cake containing their assigned goji powder daily for 30 days. Record hot flash frequency, duration, and severity using a smartphone-based electronic diary. Attend study visits at baseline, Day 15, and Day 30. Provide fasting blood samples at baseline and Day 30 for assessment of HDL cholesterol efflux capacity and cardiometabolic biomarkers. Complete computerized cognitive testing (TabCAT) at baseline and Day 30. Complete questionnaires assessing menopause-related quality of life, brain fog, mental alertness, physical activity, and study acceptability.
Interventions
- OTHER Goji Berry Juice Powder
- OTHER Goji Berry Powder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2026-06-25 |
| Est. Completion | 2027-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07660315
The ClinicalTrials.gov registry entry for NCT07660315 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Goji Berry Juice Powder is the first listed.
NCT07660315 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07660315 about?
NCT07660315 is a clinical study titled "Goji Berry and Vasomotor Symptoms Pilot Study". The goal of this clinical trial is to compare two forms of goji berry powder-whole goji berry powder and goji juice powder-in peri- and postmenopausal women aged 40-65 years who experience frequent vasomotor symptoms (hot flashes). The study aims to determine which formulation is more promising for ...
What is the current status of trial NCT07660315?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 6 participants. The study started on 2026-06-25. Estimated completion is 2027-10-31.
What interventions are being tested in trial NCT07660315?
The interventions under investigation include: Goji Berry Juice Powder (OTHER), Goji Berry Powder (OTHER).
Who is sponsoring clinical trial NCT07660315?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.